Alpha Teknova (NASDAQ:TKNO) Coverage Initiated by Analysts at Craig Hallum

Craig Hallum assumed coverage on shares of Alpha Teknova (NASDAQ:TKNO) in a report issued on Monday, MarketBeat reports. The firm issued a buy rating and a $12.00 price objective on the stock.

Alpha Teknova Trading Down 6.4 %

Shares of NASDAQ:TKNO opened at $8.05 on Monday. The company has a quick ratio of 3.94, a current ratio of 4.73 and a debt-to-equity ratio of 0.12. Alpha Teknova has a 12-month low of $1.15 and a 12-month high of $10.37. The business has a 50 day moving average of $8.48 and a 200-day moving average of $6.54. The stock has a market cap of $429.15 million, a PE ratio of -10.88 and a beta of 0.34.

Institutional Investors Weigh In On Alpha Teknova

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. JPMorgan Chase & Co. raised its position in Alpha Teknova by 622.5% during the fourth quarter. JPMorgan Chase & Co. now owns 4,400 shares of the company’s stock valued at $37,000 after purchasing an additional 3,791 shares in the last quarter. Mount Lucas Management LP bought a new position in shares of Alpha Teknova during the 4th quarter worth about $75,000. China Universal Asset Management Co. Ltd. bought a new position in shares of Alpha Teknova during the 4th quarter worth about $94,000. Bay Colony Advisory Group Inc d b a Bay Colony Advisors acquired a new stake in shares of Alpha Teknova in the 4th quarter worth about $180,000. Finally, Whalen Wealth Management Inc. purchased a new stake in Alpha Teknova in the 4th quarter valued at about $240,000. 13.81% of the stock is currently owned by institutional investors and hedge funds.

Alpha Teknova Company Profile

Alpha Teknova, Inc produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.